49 related articles for article (PubMed ID: 18547160)
1. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.
Olsnes AM; Ryningen A; Ersvaer E; Bruserud Ø
J Interferon Cytokine Res; 2008 May; 28(5):297-310. PubMed ID: 18547160
[TBL] [Abstract][Full Text] [Related]
2. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
3. T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC).
Olsnes AM; Motorin D; Ryningen A; Zaritskey AY; Bruserud Ø
Cancer Immunol Immunother; 2006 Jul; 55(7):830-40. PubMed ID: 16267679
[TBL] [Abstract][Full Text] [Related]
4. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
Westers TM; Stam AG; Scheper RJ; Regelink JC; Nieuwint AW; Schuurhuis GJ; van de Loosdrecht AA; Ossenkoppele GJ
Cancer Immunol Immunother; 2003 Jan; 52(1):17-27. PubMed ID: 12536236
[TBL] [Abstract][Full Text] [Related]
5. T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005.
Ersvaer E; Hampson P; Hatfield K; Ulvestad E; Wendelbo Ø; Lord JM; Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2007 Jun; 56(6):913-25. PubMed ID: 17115221
[TBL] [Abstract][Full Text] [Related]
6. Effects of interferon gamma on native human acute myelogenous leukaemia cells.
Ersvaer E; Skavland J; Ulvestad E; Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2007 Jan; 56(1):13-24. PubMed ID: 16612597
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.
Kharfan-Dabaja M; Ayala E; Lindner I; Cejas PJ; Bahlis NJ; Kolonias D; Carlson LM; Lee KP
Cancer Immunol Immunother; 2005 Jan; 54(1):25-36. PubMed ID: 15693136
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture.
Unterfrauner M; Rejeski HA; Hartz A; Bohlscheid S; Baudrexler T; Feng X; Rackl E; Li L; Rank A; Filippini Velázquez G; Schmid C; Schmohl J; Bojko P; Schmetzer H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139264
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1997 Oct; 45(1):45-52. PubMed ID: 9353426
[TBL] [Abstract][Full Text] [Related]
10. Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML.
Marvin J; Swaminathan S; Kraker G; Chadburn A; Jacobberger J; Goolsby C
Blood; 2011 Apr; 117(15):e120-30. PubMed ID: 21233314
[TBL] [Abstract][Full Text] [Related]
11. CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells.
Feng G; Bajpai G; Ma P; Koenig A; Bredemeyer A; Lokshina I; Lai L; Förster I; Leuschner F; Kreisel D; Lavine KJ
Circulation; 2022 Mar; 145(10):765-782. PubMed ID: 35113652
[TBL] [Abstract][Full Text] [Related]
12. The GM-CSF/CCL17 pathway in obesity-associated osteoarthritic pain and disease in mice.
Shin H; Prasad V; Lupancu T; Malik S; Achuthan A; Biondo M; Kingwell BA; Thiem M; Gottschalk M; Weighardt H; Förster I; de Steiger R; Hamilton JA; Lee KM
Osteoarthritis Cartilage; 2023 Oct; 31(10):1327-1341. PubMed ID: 37225052
[TBL] [Abstract][Full Text] [Related]
13. Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties.
Westermann J; Körner IJ; Kopp J; Kurz S; Zenke M; Dörken B; Pezzutto A
Cancer Immunol Immunother; 2003 Mar; 52(3):194-8. PubMed ID: 12649749
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia.
Spertini C; Bénéchet AP; Birch F; Bellotti A; Román-Trufero M; Arber C; Auner HW; Mitchell RA; Spertini O; Smirnova T
Cell Death Discov; 2024 Mar; 10(1):157. PubMed ID: 38548753
[TBL] [Abstract][Full Text] [Related]
15. Transforming Childhood AML Care in India.
Srinivasan S; Keerthivasagam S
J Pediatr Hematol Oncol; 2024 May; ():. PubMed ID: 38718311
[No Abstract] [Full Text] [Related]
16. The ultrasonically treated nanoliposomes containing PCV2 DNA vaccine expressing gC1qR binding site mutant Cap is efficient in mice.
Du Q; Shi T; Wang H; Zhu C; Yang N; Tong D; Huang Y
Front Microbiol; 2022; 13():1077026. PubMed ID: 36713188
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients.
Sand KE; Rye KP; Mannsåker B; Bruserud O; Kittang AO
Oncoimmunology; 2013 Feb; 2(2):e23138. PubMed ID: 23525654
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?
Ustun C; Miller JS; Munn DH; Weisdorf DJ; Blazar BR
Blood; 2011 Nov; 118(19):5084-95. PubMed ID: 21881045
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.
Smits EL; Lee C; Hardwick N; Brooks S; Van Tendeloo VF; Orchard K; Guinn BA
Cancer Immunol Immunother; 2011 Jun; 60(6):757-69. PubMed ID: 21519825
[TBL] [Abstract][Full Text] [Related]
20. Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience.
Liseth K; Ersvaer E; Hervig T; Bruserud Ø
J Biomed Biotechnol; 2010; 2010():692097. PubMed ID: 20625438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
